BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 15522186)

  • 1. [Correlation of FHIT expression to cell proliferation and metastasis of laryngeal squamous cell carcinoma].
    Yin DT; Lu XB; Dong MM; Qiu XG; Wang QZ
    Ai Zheng; 2004 Nov; 23(11):1338-41. PubMed ID: 15522186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathological significance of the fragile histidine triad transcription protein expression in laryngeal carcinogenesis.
    Kitamura K; Hayashi K; Kobayashi R; Ishii H; Matsubayashi J; Matsumoto T; Suzuki M
    Oncol Rep; 2008 Apr; 19(4):847-52. PubMed ID: 18357366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Abnormal expression of fragile histidine triad (FHIT) and Mut S homolog 2 (MSH2) proteins in human sporadic colorectal carcinoma and their clinical significance].
    Yao CC; Lin CY; Hu MB
    Ai Zheng; 2004 Mar; 23(3):310-6. PubMed ID: 15025965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Loss of fragile histidine triad expression and metastasis in breast cancer].
    Zhao P; Li XY; Chen LZ
    Ai Zheng; 2002 Jun; 21(6):668-70. PubMed ID: 12452072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expression of FHIT gene protein in laryngeal carcinoma].
    Cao L; Chen X; Wang B
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2008 Feb; 22(3):122-3. PubMed ID: 18476633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Methylation of promoter and expression of FHIT gene in laryngeal squamous cell carcinoma].
    Yin D; Dong M
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2005 Mar; 19(6):253-5, 258. PubMed ID: 16013507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Down-regulation of fragile histidine triad expression in prostate carcinoma.
    Fouts RL; Sandusky GE; Zhang S; Eckert GJ; Koch MO; Ulbright TM; Eble JN; Cheng L
    Cancer; 2003 Mar; 97(6):1447-52. PubMed ID: 12627509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Relationship between hMSH2 and FHIT gene expression in non-small cell lung cancer].
    Zhu LQ; Diao LM; Chen DJ; Li HG; Liu X; Zou ZY; Li BY; Wang M; Liu MQ
    Ai Zheng; 2003 Jun; 22(6):571-4. PubMed ID: 12948402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced acetylated histone H4 is associated with promoter methylation of the fragile histidine triad gene in resected esophageal squamous cell carcinoma.
    Tzao C; Sun GH; Tung HJ; Hsu HS; Hsu WH; Wang YC; Cheng YL; Lee SC
    Ann Thorac Surg; 2006 Aug; 82(2):396-401; discussion 401. PubMed ID: 16863736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of cyclin E overexpression in laryngeal squamous cell carcinomas.
    Dong Y; Sui L; Tai Y; Sugimoto K; Hirao T; Tokuda M
    Clin Cancer Res; 2000 Nov; 6(11):4253-8. PubMed ID: 11106240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The relationship between expression of Fhit and biological behaviors of hypopharyngeal carcinoma].
    Wu H; Luan X; Zhou W; Pan X; Xu F; Lei D
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2006 Mar; 20(6):249-50. PubMed ID: 16739375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathological significance of fragile histidine triad transcription protein expression in breast carcinoma.
    Yang Q; Yoshimura G; Suzuma T; Tamaki T; Umemura T; Nakamura M; Nakamura Y; Wang X; Mori I; Sakurai T; Kakudo K
    Clin Cancer Res; 2001 Dec; 7(12):3869-73. PubMed ID: 11751477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The expression of oncogene AKT2 in laryngeal squamous cell carcinoma and its clinical significance].
    Chen Y; He Y; Zhang S; Li L; Zhu X; Liu Y
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2009 Jun; 23(12):539-41, 545. PubMed ID: 19771908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of FHIT, CTNNB1, and MUC1 expression in non-small cell lung cancer.
    Woenckhaus M; Merk J; Stoehr R; Schaeper F; Gaumann A; Wiebe K; Hartmann A; Hofstaedter F; Dietmaier W
    Hum Pathol; 2008 Jan; 39(1):126-36. PubMed ID: 17949785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inverse correlation of aberrant expression of fragile histidine triad (FHIT) protein with cyclin D1 protein and prognosis in Chinese patients with cholangiocarcinoma.
    Zhao P; Lu Y; Zhong M; Liu L; Li B
    Acta Oncol; 2008; 47(8):1557-63. PubMed ID: 18618300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The fragile histidine triad gene: a molecular link between cigarette smoking and cervical cancer.
    Holschneider CH; Baldwin RL; Tumber K; Aoyama C; Karlan BY
    Clin Cancer Res; 2005 Aug; 11(16):5756-63. PubMed ID: 16115913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FHIT expression and hypermethylation in esophageal squamous cell carcinoma.
    Noguchi T; Takeno S; Kimura Y; Uchida Y; Daa T; Yokoyama S; Gabbert HE; Mueller W
    Int J Mol Med; 2003 Apr; 11(4):441-7. PubMed ID: 12632095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Allelic loss and down-regulation of FHIT gene expression in esophageal squamous cell carcinoma].
    Liu FX; Huang XP; Zhao CX; Xu X; Han YL; Cai Y; Wu RL; Wu M; Zhan QM; Wang MR
    Ai Zheng; 2004 Sep; 23(9):992-8. PubMed ID: 15363189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of Fhit expression is a predictor of poor outcome in tongue cancer.
    Lee JI; Soria JC; Hassan K; Liu D; Tang X; El-Naggar A; Hong WK; Mao L
    Cancer Res; 2001 Feb; 61(3):837-41. PubMed ID: 11221865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expression and significance of fragile histidine triad in oral cancer and precancerous lesions].
    Yin C; Shen LJ; Xie SM; Ruan P; Yao X
    Di Yi Jun Yi Da Xue Xue Bao; 2005 May; 25(5):584-6. PubMed ID: 15897145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.